Shailendra Dwivedi

Dr. Shailendra Dwivedi

orcid

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 July 2024 in Indian Journal of Clinical Biochemistry
Verified
Journal Article
Closed access
PDF file
SDShailendra Dwivedi
Shailendra Dwivedi
VSVijay Singh
Vijay Singh
ASAniruddha Sen
Aniruddha Sen
DYDharamveer Yadav
Dharamveer Yadav
RARuchika Agrawal
Ruchika Agrawal
PSPraveen Sharma
Praveen Sharma

1 July 2015 in Cytokine
Verified
Journal Article
Closed access
SDShailendra Dwivedi
Shailendra Dwivedi
AGApul Goel
Apul Goel
SKSanjay Khattri
Sanjay Khattri
AMAnil Mandhani
Anil Mandhani
PSPraveen Sharma
Praveen Sharma
KPKamlesh Kumar Pant
Kamlesh Kumar Pant

1 January 2014 in BioMed Research International
Verified
Journal Article
Open access
PDF file
SDShailendra Dwivedi
Shailendra Dwivedi
AGApul Goel
Apul Goel
SKSanjay Khattri
Sanjay Khattri
AMAnil Mandhani
Anil Mandhani
PSPraveen Sharma
Praveen Sharma
KPKamlesh Kumar Pant
Kamlesh Kumar Pant
Objective. Inflammation is an important hallmark of all cancers and net inflammatory response is determined by a delicate balance between pro- and anti-inflammatory cytokines, which may be affected by tobacco exposure, so the present study was designed to explore the effect of various modes of tobacco exposure on interleukin-12 (IL-12) and interleukin-10 (IL-10) inflammatory cytokine levels and survival in prostate carcinoma (PCa) patients.Methods. 285 cancer patients and equal controls with 94 BPH (benign prostatic hyperplasia) were recruited; baseline levels of serum IL-12 and IL-10 were measured and analyzed in various tobacco exposed groups by appropriate statistical tool. Five-year survivals of patients were analyzed by Log-rank (Mantel-Cox) test (graph pad version 5).Results. The expression of serum proinflammatory (IL-12) and anti-inflammatory (IL-10) cytokines was correlated with tobacco exposed group as smokers, chewers, and alcohol users have shown significantly higher levels (P<0.001) with significantly lower median survivals (27.1 months, standard error = 2.86, and 95% CI: 21.4–32.62); than nonusers. Stages III and IV of tobacco addicted patients have also shown significantly increased levels of IL-12 and IL-10.Conclusions. IL-12 and IL-10 seem to be affected by various modes of tobacco exposure and inflammation also affects median survival of cancer patients.

1 January 2011
Verified
Journal Article
Closed access
SDShailendra Dwivedi
Shailendra Dwivedi
AGApul Goel
Apul Goel
SNShanker M Natu
Shanker M Natu
AMAnil Mandhani
Anil Mandhani
SKSanjay Khattri
Sanjay Khattri
KPKamlesh K Pant
Kamlesh K Pant

17 August 2015 in The Prostate
Verified
Journal Article
Closed access
PDF file
SDShailendra Dwivedi
Shailendra Dwivedi
AGApul Goel
Apul Goel
AMAnil Mandhani
Anil Mandhani
SKSanjay Khattri
Sanjay Khattri
PSPraveen Sharma
Praveen Sharma
KPKamlesh Kumar Pant
Kamlesh Kumar Pant

28 May 2024
Verified
Book Chapter
Closed access
SDShailendra Dwivedi
Shailendra Dwivedi
VSVijay Singh
Vijay Singh
RARuchika Agrawal
Ruchika Agrawal
RMRadhieka Misra
Radhieka Misra
SASadashiv
Sadashiv
SMSanjeev Misra
Sanjeev Misra